Loading clinical trials...
Loading clinical trials...
Circulating Tumor DNA Predict Recurrence and Aid Treatment Decisions in Colon Cancer
Conditions
Interventions
OncoCare
chemotherapy for colorectal carcinoma
Locations
1
China
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Start Date
January 1, 2017
Primary Completion Date
December 1, 2017
Completion Date
September 1, 2022
Last Updated
December 20, 2016
NCT06885697
NCT05789433
NCT06121089
NCT00579163
NCT02151123
NCT05500248
Lead Sponsor
MyGenostics Inc., Beijing
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions